ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

DTC Defence Therapeutics Inc

0.518
0.00 (0.00%)
01 Aug 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type
Defence Therapeutics Inc TG:DTC Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.518 0.518 0.518 0.00 01:00:00

Domtar announces first quarter 2006 financial results

27/04/2006 2:31pm

PR Newswire (US)


Defence Therapeutics (TG:DTC)
Historical Stock Chart


From Aug 2019 to Aug 2024

Click Here for more Defence Therapeutics Charts.
DTC (TSX,NYSE) MONTREAL, April 27 /PRNewswire-FirstCall/ -- Domtar Inc. announced today a net loss of $24 million ($0.10 per common share) in the first quarter of 2006 compared to net earnings of $10 million ($0.04 per common share) in the first quarter of 2005 and a net loss of $348 million ($1.51 per common share) in the fourth quarter of 2005. > DATASOURCE: DOMTAR INC. CONTACT: Christian Tardif, Manager, Corporate and Financial Communications, (514) 848-5515, ; Investor Relations: Pascal Bosse, Manager, Investor Relations, (514) 848-5938, ; Source: Daniel Buron, Senior Vice-President and Chief Financial Officer, (514) 848-5234, To request a free copy of this organization's annual report, please go to http://www.newswire.ca/ and click on reports@cnw.

Copyright

1 Year Defence Therapeutics Chart

1 Year Defence Therapeutics Chart

1 Month Defence Therapeutics Chart

1 Month Defence Therapeutics Chart

Your Recent History

Delayed Upgrade Clock